✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Asston Pharmaceuticals Ltd.

APL

Market Cap
₹70 Cr.
P/E
18.06

Asston Pharmaceuticals Ltd.

  • Asston Pharma
  • Shelter Pharma
  • Bafna Pharmaceutical

FAQs on Asston Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

Asston Pharma is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Asston Pharma is 18.06, while 3 year average PE is 17.58.
Also latest EV/EBITDA of Asston Pharma is 0 while 3yr average is 17.35.

View FAQ's On Business

Growth Table

  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Balance Sheet

  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Cash Flow

  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Quarterly Results

  • Asston Pharmaceuticals Ltd.
  • Shelter Pharma
  • Bafna Pharmaceutical

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Asston Pharmaceuticals Ltd. Financials

Balance sheet of Asston Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Asston Pharma is decreasing.
Latest net debt of Asston Pharma is ₹3.82 Crs as of Mar-26.
This is less than Mar-25 when it was ₹6.86 Crs.

The profit is oscillating.
The profit of Asston Pharma is ₹0.52 Crs for TTM, ₹4.33 Crs for Mar 2025 and ₹1.36 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Asston Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech